A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.
Eli Lilly Chief Scientific Officer Dan Skovronsky said newer obesity medicines need to deliver more than just weight loss to ...
Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...
Companies argue they’re filling a need created by these miracle weight-loss drugs. But are they offering something of real ...
A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and ...
The FDA approved a new drug called Zepbound, which activates GLP-1 to help with obstructive sleep apnea, while also resulting ...